Patents for A61K 49 - Preparations for testing in vivo (35,376) |
---|
11/09/1995 | CA2189435A1 Polyethylene glycol derivatised dihydro or tetrahydro porphyrins, their preparation and their use as tumour localising, photosensitising compounds |
11/09/1995 | CA2189366A1 Composition for ultrasonically quantitating myocardial perfusion |
11/09/1995 | CA2188569A1 Multifunctional ligand for use as a diagnostic or therapeutic pharmaceutical |
11/09/1995 | CA2187949A1 Electron-deficient porphyrins and processes and intermediates for preparing same |
11/08/1995 | EP0680464A1 Derivated dtpa complexes, pharmaceuticals containing these compounds, their use as nmr- and radiographic contrasting agents and process for producing the same. |
11/08/1995 | EP0680341A1 Phase shift colloids as ultrasound contrast agents |
11/08/1995 | EP0680330A1 Method for identifying and treating individuals bearing cancer cells that express hla-c-clone 10/mage-1 |
11/08/1995 | EP0548096B1 Amphiphilic fluorine derivatives with telomeric structures; preparation and biomedical applications |
11/07/1995 | US5464934 Metal chelates as spacer compounds in biologically active peptides |
11/07/1995 | US5464932 Photocrosslinkable polyphosphazenes and their use as microencapsulation materials |
11/07/1995 | US5464696 Particles for NMR imaging |
11/07/1995 | US5464607 5,5'-/(1,3-propanediyl) bis-/imino(2-oxo-2,1-ethanediyl)acetylimino/bis(2,4,6-triiodo-1,3-benzenedicarboxylamides), and contrast media containing them |
11/07/1995 | US5464018 Evaluation of salt sensitivity in hypertension |
11/07/1995 | US5464013 Medical scanning and treatment system and method |
11/02/1995 | WO1995029180A1 Porphocyanine and cnc-expanded porphyrins |
11/02/1995 | WO1995028969A1 X-ray contrast compositions containing pharmaceutically acceptable clays |
11/02/1995 | WO1995028968A1 Diagnostic image analysis with metal complexes |
11/02/1995 | WO1995028967A1 Contrast agents |
11/02/1995 | WO1995028966A1 Dendrimeric compounds |
11/02/1995 | WO1995028947A1 Permeabilizer peptides for increasing blood-ocular barrier permeability |
11/02/1995 | WO1995028930A1 Dosage forms and method for ameliorating male erectile dysfunction |
11/02/1995 | EP0679163A1 Growth differentiation factor-3 |
11/02/1995 | EP0679066A1 Surfactant-stabilized microbubble mixtures, process for preparing and methods of using the same |
11/02/1995 | EP0659056A4 Artifact-free imaging contrast agent. |
11/02/1995 | DE4414757A1 Prepn. of test substances, esp. foodstuff based, for bio-metric testing |
11/02/1995 | DE19515401A1 [1,3-·1··4·C¶2¶]-Glycerin-nitrate und Verfahren zu deren Herstellung sowie diese enthaltende Lösungen [1,3 ·· · 1 · 4 C¶2¶] -glycerol-nitrate and methods for their preparation and to solutions containing |
11/02/1995 | CA2188530A1 Diagnostic image analysis with metal complexes |
11/02/1995 | CA2188292A1 Contrast agents |
11/02/1995 | CA2187921A1 Dendrimeric compounds |
11/02/1995 | CA2187459A1 Permeabilizer peptides for increasing blood-ocular barrier permeability |
11/02/1995 | CA2187019A1 X-ray contrast compositions containing pharmaceutically acceptable clays |
11/01/1995 | CN1110974A Polyaminated ligands and metal complexes thereof |
10/31/1995 | US5463080 Isotopic 5-((4-carboxy-1-oxobutyl)amino)-2,4,6-triiodo-1,3-benzenedicarboxylic acid, dimethyl ester for indirect radiohalogenation of proteins; non-deiodination in vivo |
10/31/1995 | US5463030 Metal chelating agents for medical application |
10/31/1995 | US5462725 2-pyridylmethylenepolyazamacrocyclophosphonic acids, complexes and derivatives thereof, for use as contrast agents |
10/31/1995 | US5462053 Stable artifact-free imaging contrast suspension agent |
10/26/1995 | WO1995028392A1 Chelant compounds |
10/26/1995 | WO1995028380A1 Cyclic triamine chelating agents |
10/26/1995 | WO1995028179A1 Contrast agents for diagnostic imaging |
10/26/1995 | WO1995028150A1 Photocrosslinkable polyphosphazenes and their use as microencapsulation materials |
10/26/1995 | WO1995028146A1 Fluorochemical emulsions containing 1,3-dialkylglycerophosphoryl choline surfactants and methods of use |
10/26/1995 | CA2187528A1 Chelant compounds |
10/26/1995 | CA2186600A1 Cyclic triamine chelating agents |
10/25/1995 | EP0678744A2 Method for detecting urinary tumor associated antigens |
10/25/1995 | EP0678495A2 Process for the purification of perfluoroalkylbromides or perfluoroalkylene dibromides |
10/25/1995 | EP0678101A1 Growth differentiation factor-9 |
10/25/1995 | EP0294392B1 Diagnostic and therapeutic antibody conjugates |
10/24/1995 | US5460800 Labeled fluorocarbon compositions |
10/24/1995 | US5460799 Paramagnetic, diamagnetic or ferromagnetic metal ion chelated with new iminopolycarboxylate derivatives of fatty acids |
10/24/1995 | US5460798 System for determining the quantity and identity of material ingested by user |
10/21/1995 | CA2147343A1 Process for the purification of perfluoroalkyl bromides or perfluoroalkylene dibromides |
10/19/1995 | WO1995027705A1 Aromatic amide compounds and metal chelates thereof |
10/19/1995 | WO1995027513A1 Particulate contrast media for ct enhancement of hepatic tumors |
10/19/1995 | WO1995027510A1 Screening methods for integumental inflammation modulating agents |
10/19/1995 | WO1995027481A1 Liquid delivery compositions |
10/19/1995 | WO1995027477A1 Gelified microspheres, method of preparation and applications |
10/19/1995 | WO1995027438A1 Magnetic resonance imaging using hyperpolarized noble gases |
10/19/1995 | WO1995027437A1 Microfluidization of calcium/oxyanion-containing particles |
10/19/1995 | CA2187749A1 Microfluidization of calcium/oxyanion-containing particles |
10/19/1995 | CA2187551A1 Gelified microspheres, method of preparation and applications |
10/18/1995 | EP0677332A2 Methods and apparatus for fine particle formation |
10/18/1995 | EP0677291A2 Composition and method containing optically pure (S) metoprolol |
10/18/1995 | EP0677171A1 Tetrahydroxyquinone as an activator component for activated partial thromboplastine time test of blood coagulation and as a detector of blood coagulation disorders |
10/18/1995 | EP0677108A1 Method for breeding disease resistance into plants |
10/18/1995 | EP0541704A4 Assay, methods and products based on -i(n) k?+ channel expression |
10/17/1995 | US5459238 Stimulate cytototoxic T lymphocyte immunity by interacting with human leucocyte antigen; possible AIDS vaccine |
10/17/1995 | US5459152 Platelet activating factor antagonists |
10/17/1995 | US5458870 Compositions for magnetic resonance imaging using a manganese oxalate |
10/17/1995 | US5458869 Multinuclear complexes for X-ray imaging |
10/17/1995 | US5458140 Enhancement of transdermal monitoring applications with ultrasound and chemical enhancers |
10/17/1995 | US5458127 Copolymers and their use as contrast agents in magnetic resonance imaging and in other applications |
10/12/1995 | WO1995027075A1 Biological markers of benign prostate hyperplasia |
10/12/1995 | WO1995022991A3 Block copolymers |
10/12/1995 | CA2186861A1 Biological markers of benign prostate hyperplasia |
10/11/1995 | EP0676395A2 Substituted N-heteroaroylguanidines, as inhibitors of sodium-hydrogen exchange, as antiarrhythmic agents and as inhibitors of the proliferation of cells |
10/11/1995 | EP0675904A1 Human neutralizing monoclonal antibodies to human immunodeficiency virus |
10/11/1995 | EP0675903A1 Bone resorption assay |
10/11/1995 | EP0675738A1 Aqueous injectable formulations useful for radio-diagnosis comprising iodinated aromatic compounds used as x-ray contrast media |
10/11/1995 | EP0675737A1 Immunoreactive reagents employing dihydrofolate reductase |
10/11/1995 | EP0675727A1 Glycolipid enzyme-polymer conjugates |
10/11/1995 | EP0460167B1 Humanised antibodies |
10/10/1995 | US5457183 Radiosensitizers |
10/10/1995 | US5456901 Administering liposome having encapsulated contrast enhancing agent, scanning patient using ultrasonic imaging |
10/10/1995 | US5456900 Low density microspheres and their use as contrast agents for computed tomography |
10/10/1995 | US5456663 Drugs and methods for treating diseases |
10/10/1995 | CA1337286C Continuous sonication method for preparing protein encapsulated microbubbles |
10/05/1995 | WO1995026403A1 Antibodies against e-selectin |
10/05/1995 | WO1995026354A1 New iodized boron compounds useful as x ray contrasting agents, and pharmaceutical compositions containing them |
10/05/1995 | WO1995026353A1 New iodized boron compounds useful as x-ray contrasting agents, and pharmaceutical compositions containing them |
10/05/1995 | WO1995026205A1 Liposomes |
10/05/1995 | WO1995026158A1 Method and apparatus for diagnosing erectile dysfunction |
10/05/1995 | CA2186455A1 Antibodies against e-selectin |
10/05/1995 | CA2185810A1 Liposomes |
10/04/1995 | EP0675105A1 Polyiodinated compounds, process for their preparation and diagnostic composition |
10/04/1995 | EP0674710A1 Peptides and anti-sense peptides with broad neoplastic specificity |
10/04/1995 | CN1109469A Macrocyclic bifunctional chelants, complexes threof and their antibody conjugates |
10/03/1995 | US5455158 Imaging fibrin-containing substance using labeled polypeptide imaging agent which binds to fibrin |
10/03/1995 | US5455031 Polypeptide with 46 Kdalton HMFG differentiation antigen binding specificity, composition, kit and diagnostic method |
10/03/1995 | US5455027 Poly(alkylene oxide) amino acid copolymers and drug carriers and charged copolymers based thereon |
09/28/1995 | WO1995025763A1 Branched polyoxaalkyl macromolecules, process for making them and their uses |